TCM
DMTK

Tygh Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Tygh Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-155,754
Closed -$5M – 97
2021
Q3 		$5M Sell
155,754
-4,617
-3% -$162K 0.68% 69
2021
Q2 		$6.67M Buy
160,371
+60,424
+60% +$2.48M 0.91% 56
2021
Q1 		$5.08M Buy
99,947
+79,947
+400% +$4.18M 0.72% 63
2020
Q4 		$649K Buy
+20,000
New +$284K 0.1% 88

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Tygh Capital Management's DMTK Position: Q4 2021 in Review

Tygh Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2021, closing a stake of 155,754 shares — an estimated $5M sold.

Tygh Capital Management first reported a position in DMTK in Q4 2020 and held it in 4 quarters. The position peaked at $6.67M in Q2 2021. 143 funds tracked by Wall St. Rank hold DMTK as of Q4 2021.

  • Tygh Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Tygh Capital Management sold 155,754 DermTech, Inc. Common Stock shares in Q4 2021, an estimated $5M.
  • Tygh Capital Management first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Tygh Capital Management's DermTech, Inc. Common Stock position peaked at $6.67M in Q2 2021.
  • 143 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2021.

Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.